3.06
price down icon4.67%   -0.15
after-market 시간 외 거래: 3.00 -0.06 -1.96%
loading
전일 마감가:
$3.21
열려 있는:
$3.23
하루 거래량:
190.79K
Relative Volume:
0.12
시가총액:
$40.71M
수익:
$128.60K
순이익/손실:
$-4.60M
주가수익비율:
-4.8571
EPS:
-0.63
순현금흐름:
$-3.74M
1주 성능:
+3.73%
1개월 성능:
-29.00%
6개월 성능:
+118.57%
1년 성능:
+684.41%
1일 변동 폭
Value
$2.96
$3.23
1주일 범위
Value
$2.52
$3.45
52주 변동 폭
Value
$0.2528
$4.4899

Nexalin Technology Inc Stock (NXL) Company Profile

Name
명칭
Nexalin Technology Inc
Name
전화
(832) 260-0222
Name
주소
1776 YORKTOWN, HOUSTON
Name
직원
6
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
NXL's Discussions on Twitter

NXL을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
NXL
Nexalin Technology Inc
3.06 40.71M 128.60K -4.60M -3.74M -0.63
Medical Devices icon
ABT
Abbott Laboratories
113.83 197.43B 41.22B 5.77B 6.49B 3.29
Medical Devices icon
SYK
Stryker Corp
361.52 137.82B 21.97B 3.59B 3.21B 9.33
Medical Devices icon
BSX
Boston Scientific Corp
90.69 133.66B 15.91B 1.79B 1.89B 1.21
Medical Devices icon
MDT
Medtronic Plc
80.95 103.80B 33.00B 4.29B 5.50B 3.27
Medical Devices icon
EW
Edwards Lifesciences Corp
73.91 43.59B 6.60B 4.16B 490.10M 6.93

Nexalin Technology Inc 주식(NXL)의 최신 뉴스

pulisher
Jan 01, 2025

Certain Common Stock of Nexalin Technology, Inc. are subject to a Lock-Up Agreement Ending on 2-JAN-2025. - Marketscreener.com

Jan 01, 2025
pulisher
Jan 01, 2025

Certain Options of Nexalin Technology, Inc. are subject to a Lock-Up Agreement Ending on 2-JAN-2025. - Marketscreener.com

Jan 01, 2025
pulisher
Dec 27, 2024

Nexalin Technology (NASDAQ:NXL) Shares Up 5.5% – Here’s What Happened - Defense World

Dec 27, 2024
pulisher
Dec 25, 2024

How Do Things Look For Nexalin Technology Inc (NASDAQ: NXL) In The Short-Term? - Stocks Register

Dec 25, 2024
pulisher
Dec 23, 2024

Nexalin Technology, Inc. Launches Phase 1 of AI-Driven Virtual Clinic to Enhance Mental Health Treatment - Nasdaq

Dec 23, 2024
pulisher
Dec 23, 2024

Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic - GlobeNewswire

Dec 23, 2024
pulisher
Dec 23, 2024

Nexalin Technology, Inc. Completes Phase 1 of Its Innovative Virtual Clinic - Marketscreener.com

Dec 23, 2024
pulisher
Dec 23, 2024

Nexalin Launches AI-Powered Virtual Clinic Platform for Remote Mental Health Treatment Trials - StockTitan

Dec 23, 2024
pulisher
Dec 19, 2024

Target Corp (TGT-N) QuotePress Release - The Globe and Mail

Dec 19, 2024
pulisher
Dec 19, 2024

Walmart Inc (WMT-N) QuotePress Release - The Globe and Mail

Dec 19, 2024
pulisher
Dec 07, 2024

Maxim Group Reaffirms Hold Rating for Nexalin Technology (NASDAQ:NXL) - Defense World

Dec 07, 2024
pulisher
Dec 07, 2024

Nexalin Technology’s Strong Financial Position: No Defaults on Senior Securities - MSN

Dec 07, 2024
pulisher
Dec 06, 2024

Nexalin Technology downgraded to Hold from Buy at Maxim - MSN

Dec 06, 2024
pulisher
Dec 05, 2024

Maxim Group Downgrades Nexalin Technology (NXL) - MSN

Dec 05, 2024
pulisher
Dec 05, 2024

Nexalin Technology Stock Soars to All-Time High of $4.4 Amidst Stunning Growth - Investing.com Canada

Dec 05, 2024
pulisher
Dec 02, 2024

Nexalin Technology (NASDAQ:NXL) and ENDRA Life Sciences (NASDAQ:NDRA) Head-To-Head Survey - Defense World

Dec 02, 2024
pulisher
Nov 28, 2024

Nexalin Technology, Inc. (NASDAQ:NXL) Short Interest Update - MarketBeat

Nov 28, 2024
pulisher
Nov 26, 2024

New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market - Marketscreener.com

Nov 26, 2024
pulisher
Nov 26, 2024

Nexalin Technology announces peer-reviewed publication on DIFS technology - Nasdaq

Nov 26, 2024
pulisher
Nov 26, 2024

New Peer-Reviewed Publication Validates Nexalin’s Deep - GlobeNewswire

Nov 26, 2024
pulisher
Nov 26, 2024

Nexalin's Brain Stimulation Tech Breakthrough Validated in Major Medical Journal | NXL Stock News - StockTitan

Nov 26, 2024
pulisher
Nov 25, 2024

Alibaba Group Holding ADR (BABA-N) QuotePress Release - The Globe and Mail

Nov 25, 2024
pulisher
Nov 13, 2024

Nexalin Technology stock soars to all-time high of $4.07 - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Nexalin Technology stock soars to all-time high of $4.07 By Investing.com - Investing.com UK

Nov 13, 2024
pulisher
Nov 11, 2024

Nexalin Technology CEO Provides Letter to Shareholders - GlobeNewswire

Nov 11, 2024
pulisher
Nov 11, 2024

Nexalin's Breakthrough: Alzheimer's Studies Show Promise, Secures Key Brain Tech Patent | NXL Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 10, 2024

Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Invest In Growth? - Yahoo Finance

Nov 10, 2024
pulisher
Nov 08, 2024

Nexalin Technology Inc (NXL) Quarterly 10-Q Report - Quartzy

Nov 08, 2024
pulisher
Nov 02, 2024

Nexalin regains Nasdaq compliance with bid price rule By Investing.com - Investing.com Australia

Nov 02, 2024
pulisher
Nov 02, 2024

Nexalin regains Nasdaq compliance with bid price rule - Investing.com India

Nov 02, 2024
pulisher
Nov 02, 2024

Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on November 5th - The Manila Times

Nov 02, 2024
pulisher
Nov 01, 2024

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th - GlobeNewswire

Nov 01, 2024
pulisher
Nov 01, 2024

Nexalin Technology : Regains Compliance with Nasdaq Continued Listing Requirements Form 8 K - Marketscreener.com

Nov 01, 2024
pulisher
Nov 01, 2024

Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements - The Manila Times

Nov 01, 2024
pulisher
Nov 01, 2024

LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire

Nov 01, 2024
pulisher
Oct 31, 2024

Nexalin technology's chief medical officer buys $1,095 in stock By Investing.com - Investing.com Canada

Oct 31, 2024
pulisher
Oct 30, 2024

Nexalin technology's chief medical officer buys $1,095 in stock - Investing.com India

Oct 30, 2024
pulisher
Oct 29, 2024

Significant Stock Increase For Nexalin (NXL) After Alzheimer’s Study Announcement - Stocks Telegraph

Oct 29, 2024
pulisher
Oct 28, 2024

EXCLUSIVE: Nexalin Technology Says New Data Confirms Implantable Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients - AOL

Oct 28, 2024
pulisher
Oct 28, 2024

Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease - The Manila Times

Oct 28, 2024
pulisher
Oct 28, 2024

Nexalin Technology Announces Landmark Study on Alzheimer's - GlobeNewswire

Oct 28, 2024
pulisher
Oct 28, 2024

EXCLUSIVE: Nexalin Technology Says New Data Confirms Investigational Non-Invasive Neurostimulation Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients (UPDATED) - Benzinga

Oct 28, 2024

Nexalin Technology Inc (NXL) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Nexalin Technology Inc 주식 (NXL) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Owens David
Chief Medical Officer
Aug 13 '24
Buy
0.95
1,000
950
147,793
Owens David
Chief Medical Officer
Jun 28 '24
Buy
1.75
1,000
1,750
146,793
Owens David
Chief Medical Officer
Jun 18 '24
Buy
0.71
1,619
1,149
145,793
Owens David
Chief Medical Officer
Jun 10 '24
Buy
0.64
3,000
1,920
144,174
medical_devices STE
$204.12
price up icon 0.82%
medical_devices ZBH
$104.47
price up icon 0.01%
medical_devices PHG
$25.16
price up icon 0.72%
$81.07
price up icon 3.27%
$80.52
price up icon 2.73%
medical_devices EW
$73.91
price up icon 1.82%
자본화:     |  볼륨(24시간):